Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
about
Effect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: a meta-analysisC-reactive protein levels in the brugada syndrome.Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasoundInflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?C-reactive protein in arrhythmogenic right ventricular dysplasia/cardiomyopathy and relationship with ventricular tachycardia.The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population.Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degenerationAtherosclerosis in systemic sclerosis: a systematic review and meta-analysisAssociation of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis.A biochemical fluorometric method for assessing the oxidative properties of HDL.Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis.Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicalsApolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisThe role of simvastatin in the therapeutic approach of rheumatoid arthritis.The prince and the pauper. A tale of anticancer targeted agents.Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Effect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: Double-Blind Randomized Controlled TrialThe role of dysfunctional HDL in atherosclerosis.Evaluation of the Anti-inflammatory Effects of Atorvastatin on Patients with Rheumatoid Arthritis: A Randomized Clinical TrialHDL as a biomarker, potential therapeutic target, and therapyAn abundant dysfunctional apolipoprotein A1 in human atheroma.Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.
P2860
Q26851763-3EEE13B1-5D2D-4873-8B00-682BEBBFA84FQ33160813-606919AF-0650-4160-98D9-304F6B26D2E6Q33687843-4C5B5EC0-6325-4CA2-90EA-7AE54B8AAE19Q33704086-24508227-78E5-40C7-B1E5-90FBE224FE18Q33891946-799A82DD-A2E1-4C2B-AED1-22D46233DBB9Q34143753-CB3008E4-7FB8-4A7F-A4F4-AA1A2D0EE3C6Q34398263-7859B6BF-6F10-4318-A26D-3E493CFBA6C7Q34530587-B56CCE46-7D4A-41B8-ACF3-38F048040211Q35082399-0E1FB8DA-634D-45AA-83E3-557358F43752Q35541874-CEDA902D-28BA-498F-9BD8-087452344EB9Q35562004-09D1625A-459E-4F5D-AD4E-DD764EFC69D0Q35899148-F82CB29A-9D77-4F10-B6E3-D9AB8A2D63EAQ36130121-DE366ACB-AC5D-4CD4-81AD-FF8462B43F92Q36190844-75E10D30-1A44-4C42-9AE4-804C8B5759FFQ36238859-118C56FC-860D-422B-A70E-7256F5307071Q36554649-B90447C3-5AE7-439D-90C1-CD066A9828C7Q36662681-B9C1DF1E-F05D-4F72-8FB7-A77DB19355A5Q36723319-2249A7E6-CF6F-4B0C-818D-70CA26928284Q36955395-262A3E78-C328-4278-A0A4-3434297130B8Q36959612-2B8DEE80-C162-4CCF-883C-7CDCF3793582Q37042365-5AE5B821-6AD4-44C8-A576-40F6D2D2DC72Q37058791-B98E536F-FCBE-4E88-93FA-0692778A3C53Q37102751-ECDC586C-4CCD-479B-9439-A0B18579515CQ37173198-4CCD8CDF-C644-4544-8D88-749FE02464E4Q37316891-0539C117-9F1E-4E96-86E4-6E6C01A7E654Q37429173-E670B712-34BB-48F0-8E6F-DA1AE3A49927Q37581580-05843D4C-032B-4546-A56F-AE3E4761A011Q41914520-2D95EC44-C0F7-46E4-A6F3-964FA1B60E03Q46047625-7D4AF39E-50FB-4E9B-9064-E127B5159DF3
P2860
Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Effects of high-dose atorvasta ...... toid arthritis: a pilot study.
@en
Effects of high-dose atorvasta ...... toid arthritis: a pilot study.
@nl
type
label
Effects of high-dose atorvasta ...... toid arthritis: a pilot study.
@en
Effects of high-dose atorvasta ...... toid arthritis: a pilot study.
@nl
prefLabel
Effects of high-dose atorvasta ...... toid arthritis: a pilot study.
@en
Effects of high-dose atorvasta ...... toid arthritis: a pilot study.
@nl
P2093
P1476
Effects of high-dose atorvasta ...... atoid arthritis: a pilot study
@en
P2093
Alan M Fogelman
Benjamin J Ansell
Christina Charles-Schoeman
Daniel E Furst
Dinesh Khanna
Grace S Park
Harold E Paulus
Maureen McMahon
Srinivasa T Reddy
Timothy Gong
P304
P407
P577
2007-06-01T00:00:00Z